Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Valion Bio (TIVC) Leases (2021 - 2024)

Valion Bio has reported Leases over the past 4 years, most recently at $304000.0 for Q1 2024.

  • For Q1 2024, Leases fell 36.8% year-over-year to $304000.0; the TTM value through Mar 2024 reached $304000.0, down 36.8%, while the annual FY2023 figure was $349000.0, 33.27% down from the prior year.
  • Leases for Q1 2024 was $304000.0 at Valion Bio, down from $349000.0 in the prior quarter.
  • Over five years, Leases peaked at $687000.0 in Q4 2021 and troughed at $304000.0 in Q1 2024.
  • A 4-year average of $499500.0 and a median of $502000.0 in 2022 define the central range for Leases.
  • Biggest five-year swings in Leases: fell 23.87% in 2022 and later crashed 36.8% in 2024.
  • Year by year, Leases stood at $687000.0 in 2021, then fell by 23.87% to $523000.0 in 2022, then tumbled by 33.27% to $349000.0 in 2023, then fell by 12.89% to $304000.0 in 2024.
  • Business Quant data shows Leases for TIVC at $304000.0 in Q1 2024, $349000.0 in Q4 2023, and $394000.0 in Q3 2023.